CD44 and prostate neoplasm: A slightly higher toxicity was instead observed for CD44-positive prostate tumor cells (Figure 7c), with a decrease in cell viability compared to untreated cells of ~ 30% for cells treated with bare AuNPs and ~ 35% for treatments with HA-capped NPs, respectively.